NASDAQ:RDNT - Nasdaq - US7504911022 - Common Stock - Currency: USD
59.33
-0.34 (-0.57%)
The current stock price of RDNT is 59.33 USD. In the past month the price decreased by -10.02%. In the past year, price increased by 33.78%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 11.17 | 83.60B | ||
CVS | CVS HEALTH CORP | 11.78 | 80.36B | ||
LH | LABCORP HOLDINGS INC | 17.3 | 21.02B | ||
DGX | QUEST DIAGNOSTICS INC | 19.23 | 19.25B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 16.03 | 13.83B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 148.32 | 12.14B | ||
DVA | DAVITA INC | 15.36 | 11.97B | ||
HIMS | HIMS & HERS HEALTH INC | 77.57 | 9.15B | ||
CHE | CHEMED CORP | 23.59 | 8.18B | ||
OPCH | OPTION CARE HEALTH INC | 27.17 | 5.64B | ||
CRVL | CORVEL CORP | 26.02 | 5.59B | ||
GH | GUARDANT HEALTH INC | N/A | 5.34B |
RadNet, Inc. provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company is headquartered in Los Angeles, California and currently employs 7,872 full-time employees. The company went IPO on 2001-12-12. The company has a network of 366 owned and/or operated outpatient imaging centers. The Company’s Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The Company’s Artificial Intelligence (AI) segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate and pulmonary diagnostics. The Company, through its joint ventured Arizona Diagnostic Radiology Group, LLC, owns seven outpatient imaging centers.
RADNET INC
1510 Cotner Ave
Los Angeles CALIFORNIA 90025 US
CEO: Howard G. Berger
Employees: 7872
Company Website: https://www.radnet.com/
Investor Relations: https://www.radnet.com/about-radnet/investor-relations
Phone: 13104787808
The current stock price of RDNT is 59.33 USD. The price decreased by -0.57% in the last trading session.
The exchange symbol of RADNET INC is RDNT and it is listed on the Nasdaq exchange.
RDNT stock is listed on the Nasdaq exchange.
12 analysts have analysed RDNT and the average price target is 87.89 USD. This implies a price increase of 48.14% is expected in the next year compared to the current price of 59.33. Check the RADNET INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
RADNET INC (RDNT) has a market capitalization of 4.39B USD. This makes RDNT a Mid Cap stock.
RADNET INC (RDNT) currently has 7872 employees.
RADNET INC (RDNT) has a support level at 59.32 and a resistance level at 62.53. Check the full technical report for a detailed analysis of RDNT support and resistance levels.
The Revenue of RADNET INC (RDNT) is expected to grow by 13.13% in the next year. Check the estimates tab for more information on the RDNT EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
RDNT does not pay a dividend.
RADNET INC (RDNT) will report earnings on 2025-02-27, after the market close.
The PE ratio for RADNET INC (RDNT) is 97.26. This is based on the reported non-GAAP earnings per share of 0.61 and the current share price of 59.33 USD. Check the full fundamental report for a full analysis of the valuation metrics for RDNT.
The outstanding short interest for RADNET INC (RDNT) is 8.73% of its float. Check the ownership tab for more information on the RDNT short interest.
ChartMill assigns a technical rating of 1 / 10 to RDNT. When comparing the yearly performance of all stocks, RDNT turns out to be only a medium performer in the overall market: it outperformed 61.7% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to RDNT. RDNT has only an average score on both its financial health and profitability.
Over the last trailing twelve months RDNT reported a non-GAAP Earnings per Share(EPS) of 0.61. The EPS increased by 48.78% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -0.13% | ||
ROE | -0.49% | ||
Debt/Equity | 1.11 |
ChartMill assigns a Buy % Consensus number of 85% to RDNT. The Buy consensus is the average rating of analysts ratings from 12 analysts.
For the next year, analysts expect an EPS growth of 21.89% and a revenue growth 13.13% for RDNT